Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

Dicot Pharma

0.38 SEK

-0.11 %

Less than 1K followers

DICOT

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Dicot Pharma

EV/S

Median 2022-2023

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)1.080.490.340.160.230.240.31
Shares42.161.2106.7281.41,111.61,778.82,009.3
Market cap45.629.936.146.1260.0431.4616.9
Enterprise value33.49.55.836.7212.6--
EV/S---305.7924.5--
EV/EBITDAneg.neg.neg.neg.neg.--
EV/EBITneg.neg.neg.neg.neg.--
P/Eneg.neg.neg.neg.neg.neg.neg.
P/B3.571.521.278.595.863.868.40
P/S---383.91,130.4--
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio91.0 %91.0 %89.2 %43.3 %82.9 %90.4 %85.8 %
Gearing ratio-------
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.